![Blue and purple bubbles](/cdn-cgi/image/format=auto/globalassets/sitewide-hero-stock/feed-heroes/feed-hero-2.webp?preset=df)
Drug Database
L04AG04 belimumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Benlysta 400 mg powder for concentrate for solution for infusion (Northern Ireland) ▼
- POM Benlysta 200 mg solution for injection in pre-filled pen (Northern Ireland) ▼
- POM Benlysta 120 mg powder for concentrate for solution for infusion (Northern Ireland) ▼
- POM Benlysta 200 mg solution for injection in pre-filled pen/pre-filled syringe ▼
- POM Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).